Cellectis S.A. Operating Cycle 2011-2026 | CLLS

Annual Operating Cycle Cellectis S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	136	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
136	136	136

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Biogen BIIB	452	$ 172.65	0.62 %	$ 25.1 B	USA
Adagene ADAG	53.8	$ 2.38	-4.22 %	$ 134 M	China
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Aptorum Group Limited APM	4.89	$ 0.98	1.35 %	$ 5.34 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Catalyst Biosciences CBIO	410	$ 12.1	-5.47 %	$ 797 M	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
BioXcel Therapeutics BTAI	244	$ 1.78	-2.47 %	$ 4.51 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	8.75	$ 67.14	0.13 %	$ 8.98 B	USA
Compugen Ltd. CGEN	60.8	$ 2.05	-1.91 %	$ 184 M	Israel
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Amphastar Pharmaceuticals AMPH	195	$ 26.56	2.45 %	$ 1.29 B	USA
Coherus BioSciences CHRS	379	$ 2.25	9.22 %	$ 212 M	USA
Amneal Pharmaceuticals AMRX	123	$ 13.58	1.42 %	$ 4.2 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Celldex Therapeutics CLDX	86.5	$ 26.54	2.41 %	$ 1.71 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	360	$ 2.75	1.84 %	$ 17.3 M	USA
AstraZeneca PLC AZN	206	$ 94.2	1.34 %	$ 96.9 B	Britain
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA